A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years
Conditions: Influenza; Swine-origin A/H1N1 InfluenzaInterventions: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated); Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant); Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)Sponsors: Sanofi; Sanofi Pasteur, a Sanofi CompanyCompleted - verified January 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: H1N1 | Influenza | Influenza Vaccine | Research | Study | Swine Flu | Swine Flu (H1N1) Vaccine | Vaccines